These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26856947)

  • 1. Regulatory T cell number in multiple sclerosis patients: A meta-analysis.
    Noori-Zadeh A; Mesbah-Namin SA; Bistoon-Beigloo S; Bakhtiyari S; Abbaszadeh HA; Darabi S; Rajabibazl M; Abdanipour A
    Mult Scler Relat Disord; 2016 Jan; 5():73-6. PubMed ID: 26856947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
    Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
    J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of CD8
    Seidkhani-Nahal A; Noori-Zadeh A; Bakhtiyari S; Khosravi A
    Acta Neurol Belg; 2019 Mar; 119(1):61-68. PubMed ID: 30324330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.
    Abdulahad WH; Stegeman CA; van der Geld YM; Doornbos-van der Meer B; Limburg PC; Kallenberg CG
    Arthritis Rheum; 2007 Jun; 56(6):2080-91. PubMed ID: 17530650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
    Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
    Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4(+)CD25(+)FOXP3(+)CD31(+) T-cells in patients with multiple sclerosis.
    Haas J; Korporal M; Balint B; Fritzsching B; Schwarz A; Wildemann B
    J Neuroimmunol; 2009 Nov; 216(1-2):113-7. PubMed ID: 19646767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis.
    Sugimoto N; Oida T; Hirota K; Nakamura K; Nomura T; Uchiyama T; Sakaguchi S
    Int Immunol; 2006 Aug; 18(8):1197-209. PubMed ID: 16772372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
    Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
    J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.
    Keever-Taylor CA; Browning MB; Johnson BD; Truitt RL; Bredeson CN; Behn B; Tsao A
    Cytotherapy; 2007; 9(2):144-57. PubMed ID: 17453966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The subpopulation CD4(+); CD25(+); Foxp3(+);/CD127(low/-); regulatory T cells in peripheral blood of HIV-infected patients correlated with disease progression].
    Chen YL; Chen XR; Qin LX; Yang YF; Tang YM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1188-91. PubMed ID: 23127412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4(+)HLA-G(+) regulatory T cells: Molecular signature and pathophysiological relevance.
    Pankratz S; Ruck T; Meuth SG; Wiendl H
    Hum Immunol; 2016 Sep; 77(9):727-33. PubMed ID: 26826445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased regulatory T-cell numbers are associated with farm milk exposure and lower atopic sensitization and asthma in childhood.
    Lluis A; Depner M; Gaugler B; Saas P; Casaca VI; Raedler D; Michel S; Tost J; Liu J; Genuneit J; Pfefferle P; Roponen M; Weber J; Braun-Fahrländer C; Riedler J; Lauener R; Vuitton DA; Dalphin JC; Pekkanen J; von Mutius E; Schaub B;
    J Allergy Clin Immunol; 2014 Feb; 133(2):551-9. PubMed ID: 23993223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compromised CD4+ CD25(high) regulatory T-cell function in patients with relapsing-remitting multiple sclerosis is correlated with a reduced frequency of FOXP3-positive cells and reduced FOXP3 expression at the single-cell level.
    Venken K; Hellings N; Thewissen M; Somers V; Hensen K; Rummens JL; Medaer R; Hupperts R; Stinissen P
    Immunology; 2008 Jan; 123(1):79-89. PubMed ID: 17897326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of circulating allergen-specific CD4+CD25highFoxp3+ T-regulatory cells in both nonatopic and atopic individuals.
    Maggi L; Santarlasci V; Liotta F; Frosali F; Angeli R; Cosmi L; Maggi E; Romagnani S; Annunziato F
    J Allergy Clin Immunol; 2007 Aug; 120(2):429-36. PubMed ID: 17604089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of Runx1 and lowered proportion of Foxp3⁺ CD25⁺ CD4⁺ regulatory T cells in systemic sclerosis.
    Kataoka H; Yasuda S; Fukaya S; Oku K; Horita T; Atsumi T; Koike T
    Mod Rheumatol; 2015 Jan; 25(1):90-5. PubMed ID: 24716598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
    Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tim3
    Sun H; Gao W; Pan W; Zhang Q; Wang G; Feng D; Geng X; Yan X; Li S
    Inflammation; 2017 Aug; 40(4):1342-1350. PubMed ID: 28478516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low circulating CD4(+) CD25(+) Foxp3(+) T regulatory cell levels predict miscarriage risk in newly pregnant women with a history of failure.
    Winger EE; Reed JL
    Am J Reprod Immunol; 2011 Oct; 66(4):320-8. PubMed ID: 21314851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significantly enhanced frequency of functional CD4+CD25+Foxp3+ T regulatory cells in therapeutic dose aspirin-treated mice.
    Javeed A; Zhang B; Qu Y; Zhang A; Sun C; Zhang L; Liu J; Zeng C; Zhao Y
    Transpl Immunol; 2009 Mar; 20(4):253-60. PubMed ID: 19146957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.